are compound semaglutide going away Despite FDA ruling, compounded GLP-1s still giving Novo and Lilly headaches on the market Now that shortages of semaglutide

Avoid Skipping Medication: While vacation may seem like an opportunity to take a break from your daily routine, it's generally not advisable to skip GLP-1 medication

In March, Eli Lilly announced results of TRASCEND T2D-1-its phase-3 study on retatrutide

Dosing & Administration: Both are once-weekly subcutaneous injections

It also means the initial side effect window falls on Friday night and Saturday, minimizing workday disruption

GLP-1s and biological ageing GLP-1s have attracted interest as gerotherapeutics, according to the authors of a small new study that looked at whether semaglutide could slow down biological ageing in people with HIV

Phase 2 data published in 2023 reported mean body-weight reductions of up to 24.2% at 48 weeks on the highest dose tier (Jastreboff et al., NEJM 2023)